Linked Life Data

17206975

Source:http://linkedlifedata.com/resource/pubmed/id/17206975

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2007-1-8
pubmed:abstractText
The development of tocolytic medications faces challenges common to all drug development programmes, principally related to evolving understanding of the pathophysiology. There are unique impediments to drug development for pregnancy-related conditions in general and for tocolysis in particular. The purpose of this brief overview is to familiarize the obstetrician with the current challenges to drug development, focusing in particular on the problems of tocolytic development. A strategy for encouraging drug development for preterm labour and for pregnancy-related problems in general is presented.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1470-0328
pubmed:author
pubmed:issnType
Print
pubmed:volume
113 Suppl 3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
100-4
pubmed:dateRevised
2008-3-25
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Regulatory and methodologic challenges to tocolytic development.
pubmed:affiliation
University of Southern California, Women's and Children's Hospital, Los Angeles, CA, USA. tgoodwin@usc.edu
pubmed:publicationType
Journal Article, Review